← Eichor
Study identifier: NCT04368039 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

Condition: Psychosis · Schizophrenia · First-episode Psychosis  ·  Sponsor: Nicholas Breitborde

PhaseNA
Planned participants20
Who can joinAll sexes, 15 Years to 35 Years
Healthy volunteersNo

About this study

Single-blind, randomized controlled trial of normobaric oxygen therapy among individuals with first-episode psychosis: Effects on symptomatology and cognition.

This description comes directly from the study's public registry record.

Talk to the study team

Nicholas Breitborde, PhD  ·  (614) 685-6052  ·  nicholas.breitborde@osumc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Harding HospitalColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04368039